孕期sFlt-1/PlGF比值升高与产后3-6年主观记忆障碍的关联研究
本研究为西班牙巴塞罗那某三级医院的横断面研究,纳入266名孕期招募并于产后3-6年随访的个体,其中81例(30.45%)有子痫前期病史。研究评估孕期血管生成失衡(sFlt-1/PlGF比值≥38)与产后主观记忆障碍(MFE总分≥36)的关联。结果显示,血管生成失衡组记忆障碍患病率更高(30.0% vs 16.2%,P=.03),多因素分析中比值比=2.18(95%CI 1.02-4.65,P=.04),而子痫前期诊断本身无显著关联。
要点
- 孕期sFlt-1/PlGF≥38与产后3-6年主观记忆障碍风险增加2.18倍相关
- 子痫前期诊断本身不显著预测远期记忆障碍,血管生成失衡更具特异性
- 血管生成生物标志物可能作为产后认知风险的早期预警指标
核心结论
- 孕期sFlt-1/PlGF比值升高与产后3-6年主观记忆障碍风险增加独立相关
- 血管生成失衡可作为产后认知脆弱性的潜在早期指标,支持纵向随访和预防策略
研究设计与样本
- 横断面研究,西班牙巴塞罗那三级医院
- 266名孕期前瞻性招募个体,产后3-6年再评估(2023年8月至2025年2月)
- 子痫前期按ACOG标准定义,sFlt-1/PlGF≥38(孕28-40周测定)代表血管生成失衡
主要发现
- 血管生成失衡组记忆障碍患病率30.0%,正常组16.2%(P=.03)
- 多因素分析中,血管生成失衡与记忆障碍的比值比=2.18(95%CI 1.02-4.65,P=.04)
- 子痫前期诊断本身与记忆结局无显著关联(比值比=1.35,95%CI 0.70-2.60,P=.37)
关键数值与推荐
- 血管生成失衡定义为sFlt-1/PlGF比值≥38(孕28-40周)
- 主观记忆障碍定义为MFE问卷总分≥36
- 子痫前期采用ACOG诊断标准
临床怎么用
- 临床可考虑对有孕期sFlt-1/PlGF升高史的产妇进行产后认知随访
- 该比值可能比子痫前期诊断更有助于识别远期记忆风险个体
- 仍需纵向研究验证,并探索针对性的预防干预措施
局限性
- 横断面设计无法确立因果关系
- 样本量有限(266例),可能影响统计效力
- 主观记忆评估而非客观认知测试,且未报告失访率
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preeclampsia is a pregnancy-related disorder characterized by systemic endothelial dysfunction and angiogenic imbalance, most notably elevated levels of soluble fms-like tyrosine kinase-1 and decreased placental growth factor. While preeclampsia has been associated with long-term cardiovascular and cognitive risks, the specific role of angiogenic imbalance in predicting postpartum memory impairment remains unclear. Identifying biomarkers that can anticipate future neurocognitive outcomes may offer opportunities for early intervention and monitoring. OBJECTIVE: To evaluate whether preeclampsia and angiogenic imbalance during pregnancy, defined by a soluble fms-like tyrosine kinase-1/placental growth factor ratio ≥38, are associated with subjective memory impairment 3 to 6 years postpartum. STUDY DESIGN: Cross-sectional study at a tertiary hospital in Barcelona, Spain. Individuals were prospectively recruited during pregnancy and reevaluated 3 to 6 years postpartum. Preeclampsia was defined per American College of Obstetricians and Gynecologists criteria. Angiogenic imbalance during pregnancy was defined as soluble fms-like tyrosine kinase-1/placental growth factor ≥38 (determined between 28 and 40 weeks of gestation). Subjective memory performance was assessed using the validated Memory Failures of Everyday Life questionnaire. Memory impairment was defined as a total Memory Failures of Everyday Life score ≥36. Logistic and linear regression models were used to examine associations, adjusting for relevant confounders. RESULTS: A total of 266 individuals were reevaluated between August 2023 and February 2025. 81 of them (30.45%) had a documented history of preeclampsia. Participants with an elevated soluble fms-like tyrosine kinase-1/placental growth factor ratio during pregnancy showed a higher prevalence of memory impairment (30.0% vs 16.2%, P=.03). In multivariable analysis, angiogenic imbalance remained significantly associated with increased odds of memory impairment (odds ratio=2.18, 95% confidence interval [1.02-4.65], P=.04). In contrast, preeclampsia diagnosis alone was not significantly associated with memory outcomes (odds ratio=1.35, 95% confidence interval [0.70-2.60], P=.37). CONCLUSION: An elevated soluble fms-like tyrosine kinase-1/placental growth factor ratio during pregnancy is associated with an increased risk of subjective memory impairment 3 to 6 years postpartum. These findings highlight the potential utility of angiogenic biomarkers as early indicators of long-term cognitive vulnerability, supporting the need for longitudinal follow-up and targeted preventive strategies in women exposed to angiogenic imbalance during pregnancy.
引用
- Platero, Garcia-Manau, Costa, et al. Abnormal soluble fms-like tyrosine kinase to placental growth factor ratio during pregnancy and subjective memory impairment 3 to 6 years postpartum. Am J Obstet Gynecol. 2026. PMID: 41724313. doi:10.1016/j.ajog.2026.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。